Pharmacokinetics of saquinavir hard gel/ritonavir (1000/100 mg twice daily) when administered with tenofovir diproxil fumarate in HIV-1-infected subjects
Open Access
- 16 December 2004
- journal article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 59 (1) , 38-42
- https://doi.org/10.1111/j.1365-2125.2004.02240.x
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Intra-individual variability in lopinavir plasma trough concentrations supports therapeutic drug monitoringAIDS, 2003
- Tenofovir‐Related Nephrotoxicity in Human Immunodeficiency Virus–Infected Patients: Three Cases of Renal Failure, Fanconi Syndrome, and Nephrogenic Diabetes InsipidusClinical Infectious Diseases, 2003
- Fatal Lactic Acidosis and Acute Renal Failure after Addition of Tenofovir to an Antiretroviral Regimen Containing DidanosineClinical Infectious Diseases, 2003
- Renal lesions in HIV-1-positive patient treated with tenofovirAIDS, 2003
- Tenofovir: A Nucleotide Analog for The Management of Human Immunodeficiency Virus InfectionPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2003
- Rapid Communication: Acute Renal Failure Associated with Tenofovir: Evidence of Drug-Induced NephrotoxicityThe Lancet Healthy Longevity, 2002
- Fanconi syndrome and renal failure induced by tenofovir: A first case reportAmerican Journal of Kidney Diseases, 2002
- Therapeutic drug monitoring in HIV infection: current status and future directionsAIDS, 2002
- Interactions among Drugs for HIV and Opportunistic InfectionsNew England Journal of Medicine, 2001
- Clinical Pharmacokinetics of the Antiviral Nucleotide Analogues Cidofovir and AdefovirClinical Pharmacokinetics, 1999